Insider Transactions of Holly Kordasiewicz at IONIS PHARMACEUTICALS INC

On June 12, 2026, Holly Kordasiewicz, EVP, Chief Development Officer of IONIS PHARMACEUTICALS INC (IONS), executed a series of transactions involving the company's Common Stock. Kordasiewicz acquired a total of 59,846 shares through various means, including exercising stock options and other acquisitions at prices ranging from $32.60 to $60.89. Simultaneously, Kordasiewicz disposed of 60,846 shares. The disposals included 41,004 shares sold under a Rule 10b5-1 Trading Plan at a weighted average price of $73.09, and 19,842 shares also sold under the same plan at a weighted average price of $74.05. These transactions resulted in a net change in Kordasiewicz's holdings, with post-transaction ownership levels detailed in the filing. The filing also notes the exercise of certain stock options with varying exercise prices and expiration dates, all linked to the underlying Common Stock.